Zhejiang Shengda Bio-Pharm Co., Ltd. (SHSE:603079) announces a share repurchase program. Under the program, the company will repurchase its own shares for a total of CNY 34 million. The shares will be purchased at a price not exceeding CNY 17 per share.

The repurchased shares will be used for the implementation of equity incentive plan. If the company fails to implement the above-mentioned purposes within the time limit stipulated by laws and regulations, there is a risk of initiating the cancellation procedure of the un-transferred part. The program will be funded from company's own funds.

The program will be valid for 12 months.